Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma

Leuk Lymphoma. 2023 Jan;64(1):234-237. doi: 10.1080/10428194.2022.2133542. Epub 2022 Oct 19.

Aliza Gardenswartz¹, Brinda Mehta², Nader Kim El-Mallawany³, Carmella van de Ven¹, Jessica Hochberg¹, Allyson Flower⁴, Erin Morris¹, Lauren Harrison¹, Yaya Chu¹, Jaclyn Basso¹, Perry Gerard⁵, Humayun Islam⁶, Janet Ayello¹, Lee Ann Baxter-Lowe⁷, Mitchell S Cairo^{1

6

8

9

10}

¹ Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
² Department of Pediatrics, St. Jude Children's Research Hospital, Peoria, IL, USA.
³ Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
⁴ Department of Pediatrics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.
⁵ Department of Radiology, New York Medical College, Valhalla, NY, USA.
⁶ Department of Pathology, New York Medical College, Valhalla, NY, USA.
⁷ Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, CA, USA.
⁸ Department of Medicine, New York Medical College, Valhalla, NY, USA.
⁹ Department of Microbiology and Immunology, New York Medical College, Valhalla, NY, USA.
¹⁰ Department of Cell Biology and Anatomy, Hematology and Stem Cell Transplantation, Valhalla, NY, USA.

No abstract available

Publication types